Belantamab mafodotin Interactions
There are 164 drugs known to interact with belantamab mafodotin, along with 3 disease interactions. Of the total drug interactions, 45 are major, and 119 are moderate.
- View all 164 medications that may interact with belantamab mafodotin
- View belantamab mafodotin disease interactions (3)
Most frequently checked interactions
View interaction reports for belantamab mafodotin and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- Arava (leflunomide)
- Arcapta (indacaterol)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- Copaxone (glatiramer)
- Corlanor (ivabradine)
- Cosmegen (dactinomycin)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Cytoxan (cyclophosphamide)
- Darzalex Faspro (daratumumab / hyaluronidase)
- Deca-Durabolin (nandrolone)
Belantamab mafodotin disease interactions
There are 3 disease interactions with belantamab mafodotin which include:
More about belantamab mafodotin
- belantamab mafodotin consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.